Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPAR γ/CD36 signaling pathway
In conclusion, the present study confirmed the roles of Gal3 in hepatic lipid metabolism in both in vitro and in vivo studies and revealed that Gal3 is a secretory protein that promotes hepatic steatosis through the PPARγ-CD36-dependent pathway, suggesting that targeting Gal3 may represent a potential therapeutic approach for the treatment of NAFLD and related metabolic disorders.PMID:33991615 | DOI:10.1016/j.cellsig.2021.110043
Source: Cellular Signalling - Category: Cytology Authors: Huiyuan Yu Fan Yang Wentao Zhong Xin Jiang Fan Zhang Xueying Ji Mengjuan Xue Yixuan Qiu Jiaming Yu Xiaona Hu Jie Chen Zhijun Bao Source Type: research
More News: Alcoholism | Cytology | Diets | Fatty Liver Disease (FLD) | High Fat | Insulin | Liver | Liver Disease | Men | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Study | Urology & Nephrology